GSK and Spero Therapeutics’ Phase III trial of their oral antibiotic for complicated urinary tract infections (cUTI) will end early after successfully meeting its primary endpoint. The decision to end ...

GennaMD provides bacteria-fighting power in a small capsule, powered by 36 mg of soluble PAC derived only from 100% cranberry ...

Treating urine infections is becoming increasingly challenging due to rising antibiotic resistance. Here's what's driving ...

The FDA has approved a new antibiotic that can treat uncomplicated urinary tract infections, or uUTIs. It’s the first new class of oral antibiotics for UTIs in almost 30 years, according to developer ...

GSK and Spero Therapeutics’ Phase III trial of their oral antibiotic for complicated urinary tract infections (cUTI) will end early after successfully meeting its primary endpoint. The decision ...

Delayed empiric antibiotics in kidney transplant patients with urosepsis are strongly linked to increased mortality and AKI ...

Swiss pharmaceutical firm Roche has advanced its antibiotic candidate, zosurabalpin, into Phase 3 clinical trials, ...

British pharmaceutical company GSK PLC (GSK) and its Massachusetts-based partner Spero Therapeutics (SPRO) said on Wednesday that they are stopping their late-stage trial evaluating the efficacy of ...

A new Rutgers Health study reveals a surprising twist in the antibiotic resistance story: instead of simply killing bacteria, ...

After menopause, urinary tract infections (UTIs) can be more frequent, yet most women don’t realise the two are associated. And the main culprit for increased UTIs in menopausal women is the drop in ...

A new study from Rutgers Health shows that ciprofloxacin, a staple treatment for urinary tract infections, throws Escherichia ...

It's usually prescribed to bring relief for a specific type of infection, but officials now say there's a "microbial ...